EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Type II tRNA cleavage by SLFN14 endoribonuclease variants linked to inherited thrombocytopenia drives global translational repression

Chengchao Ding, Xinyi Ashley Liu, Fushun Zhang, Saori Uematsu, Shu-Bing Qian, Yan Xiang iD

PLOS Biology · 29.05.2026 · 24 (5) · e3003830

DOI: 10.1371/journal.pbio.3003830 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Biology, online erschienen am 29.05.2026. Verfasst von Chengchao Ding und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology‌‌ and Molecular Genetics, Joe R. & Teresa Lozano Long School of Medicine, The University of Texas at San Anton…. Hauptthemen laut MEDLINE: Protein Biosynthesis, Endoribonucleases, RNA, Transfer, Thrombocytopenia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Texas Health Science Center at San Antonio.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Schlafens proteins (SLFNs) are interferon-inducible regulators of RNA metabolism that influence antiviral defense and cell fate. Human SLFN14 is a ribosome-associated endoribonuclease whose pathogenic variants cause autosomal dominant inherited thrombocytopenia (IT), but the molecular basis of this disorder remains unclear. Here, using HEK293T cells expressing human SLFN14 variants, we show that SLFN14 represses global protein synthesis through selective cleavage of type II tRNAs. IT-linked mutations alter SLFN14 RNA substrate specificity, enhancing depletion of type II tRNAs while reducing rRNA cleavage. This shift promotes ribosome stalling at codons decoded by type II tRNAs, triggering global translational arrest, stress signaling, and cell death. These findings reveal how altered RNA targeting by SLFN14 can drive disease and highlight selective tRNA targeting as a mechanism than regulates translation and cell fate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein BiosynthesisEndoribonucleasesRNA, TransferThrombocytopeniaNuclear ProteinsHumansHEK293 CellsMutationRibosomesSubstrate Specificity

Substanzen

EndoribonucleasesRNA, TransferNuclear Proteins

Autor:innen und Institutionen

  • Department of Microbiology, Immunology‌‌ and Molecular Genetics, Joe R. & Teresa Lozano Long School of Medicine, The University of Texas at San Antonio, San Antonio, Texas, New York, United States of America.
  • Department of Infectious Disease, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
  • Division of Nutritional Sciences, Cornell University, Texas, New York, United States of America.

ORCID-Profile: Yan Xiang

Förderung

  • University of Texas Health Science Center at San Antonio

Zitieren

APA

Ding, C., Liu, X. A., Zhang, F., Uematsu, S., Qian, S. B., & Xiang, Y. (2026). Type II tRNA cleavage by SLFN14 endoribonuclease variants linked to inherited thrombocytopenia drives global translational repression. PLOS Biology, 24(5), e3003830. https://doi.org/10.1371/journal.pbio.3003830

Vancouver

Ding C, Liu XA, Zhang F, Uematsu S, Qian SB, Xiang Y. Type II tRNA cleavage by SLFN14 endoribonuclease variants linked to inherited thrombocytopenia drives global translational repression. PLOS Biology. 2026;24(5):e3003830. doi:10.1371/journal.pbio.3003830

BibTeX
@article{Ding2026,
  author = {Ding, Chengchao and Liu, Xinyi Ashley and Zhang, Fushun and Uematsu, Saori and Qian, Shu-Bing and Xiang, Yan},
  title = {Type II tRNA cleavage by SLFN14 endoribonuclease variants linked to inherited thrombocytopenia drives global translational repression},
  journal = {PLOS Biology},
  year = {2026},
  volume = {24},
  number = {5},
  pages = {e3003830},
  doi = {10.1371/journal.pbio.3003830}
}
Kostenlos starten →